Oncology & Cancer

Many targeted cancer therapies suppress T cell immune responses

In many cases, targeted therapies for cancer are preferred as treatments over chemotherapy and surgery because they attack and kill cancer cells with specific tumor-promoting mutations while sparing healthy, normal cells ...

Oncology & Cancer

New direction urged to improve cancer nanotechnology

Researchers involved in a national effort to develop cancer treatments that harness nanotechnology are recommending pivotal changes in the field because experiments with laboratory animals and efforts based on current assumptions ...

Immunology

Lymphoma: How the tumor escapes the immune response

Natural killer cells of the immune system can fend off malignant lymphoma cells and thus are considered a promising therapeutic approach. However, in the direct vicinity of the tumor they lose their effect. Scientists of ...

Oncology & Cancer

Researchers reprogram tumor's cells to attack itself

Inserting a specific strain of bacteria into the microenvironment of aggressive ovarian cancer transforms the behavior of tumor cells from suppression to immunostimulation, researchers at Norris Cotton Cancer Center and the ...

page 35 from 40